- $186.85bn
- $188.37bn
- $35.82bn
- 86
- 39
- 87
- 81
2019 September 29th | 2020 September 27th | 2021 September 26th | 2022 September 25th | 2023 September 24th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19,573 | 21,731 | 33,566 | 44,200 | 35,820 |
Cost of Revenue | |||||
Gross Profit | 10,974 | 12,476 | 19,304 | 25,565 | 19,951 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 12,041 | 15,881 | 23,810 | 28,387 | 28,164 |
Operating Profit | 7,532 | 5,850 | 9,756 | 15,813 | 7,656 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,481 | 5,719 | 10,274 | 14,998 | 7,443 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4,386 | 5,198 | 9,043 | 12,986 | 7,339 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 4,386 | 5,198 | 9,043 | 12,936 | 7,232 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4,386 | 5,198 | 9,043 | 12,936 | 7,232 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.6 | 3.4 | 7.9 | 10.7 | 7.39 |
Dividends per Share |